Related Experiment Video
Updated: Jun 24, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Fatal infection in children with lupus nephritis treated with intravenous cyclophosphamide
Kamolwish Laoprasopwattana1, Pornsak Dissaneewate, Prayong Vachvanichsanong
1Department of Pediatrics, Prince of Songkla University, Songkhla, Thailand. kamolwish@yahoo.com
Insights
Fatal infections in childhood lupus nephritis (LN) patients treated with intravenous cyclophosphamide (IVCY) are linked to prior pulse methylprednisolone, renal failure, and fungal infections. Early identification of fungal infections is crucial for improving outcomes.
Area of Science:
- Pediatric Nephrology
- Infectious Diseases
- Immunology
Background:
- Childhood lupus nephritis (LN) treatment often involves immunosuppressants like intravenous cyclophosphamide (IVCY).
- Severe infections pose a significant risk to patients with LN undergoing immunosuppressive therapy.
- Understanding risk factors for fatal infections is crucial for optimizing treatment strategies.
Purpose of the Study:
- To identify the causes and risk factors associated with fatal infections in children with lupus nephritis treated with IVCY.
- To inform clinical practice and improve patient outcomes by elucidating predictors of mortality.
Main Methods:
- Retrospective analysis of 84 childhood lupus nephritis patients treated between 1996-2007.
- Detailed review of severe infection episodes, causative organisms, and patient characteristics.
- Multivariate analysis to determine independent risk factors for fatal infections.
Main Results:
- 36.9% of patients experienced severe infections, with a 41.9% mortality rate among those infected.
- Major causes of fatal infections included fungi and Gram-negative bacilli.
- Risk factors for fatal infection included prior pulse methylprednisolone, renal failure, and fungal infection.
Conclusions:
- Prior pulse methylprednisolone, renal failure, and fungal infections are significant predictors of fatal outcomes in childhood LN patients on IVCY.
- Aggressive investigation for fungal infections is warranted in patients with active LN, IVCY, and pulse methylprednisolone who develop severe, antibiotic-refractory infections.
Abstract:
A knowledge of the causes and risk factors of fatal infection in childhood lupus nephritis (LN) patients treated with intravenous cyclophosphamide (IVCY) is important to enable optimal treatment. During an 11-year period (1996-2007), severe infection cases occurred in 31/84 (36.9%) patients with 64 infection episodes in our central referral institution in southern Thailand. Fatal infections occurred in 13/31 (41.9%) patients, most (11/13, 84.6%) during the first infective episode. The major causative organisms of the fatal infections were fungus and Gram-negative bacilli. Fatal infections were more likely to occur in patients with a prior history of treatment with pulse methylprednisolone and in patients with more active LN, as evidenced by the higher proteinuria and serum creatinine levels and lower hemoglobin and lymphocyte counts in this group than in patients with non-fatal infections. Multivariate analysis indicated that factors associated with fatal infection were prior treatment with pulse methylprednisolone [odds ratio (OR) 11.2, 95% confidence interval (CI) 1.9-61.0], renal failure (OR 5.9, 95% CI 1.0-34.8), and fungal infection (OR 23.9, 95% CI 1.9-298.2). Cases of active LN treated with IVCY and pulse methylprednisolone who later develop severe infection that fails to respond to antibiotics should be carefully investigated for fungal infection.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Pyelonephritis II: Diagnostic Studies and Management
Kidney Transplant II: Surgical Procedure
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Pyelonephritis I: Introduction